FXa inhibition by rivaroxaban modifies mechanisms associated with the pathogenesis of human abdominal aortic aneurysms-Reference-Cited by-同舟云学术

FXa inhibition by rivaroxaban modifies mechanisms associated with the pathogenesis of human abdominal aortic aneurysms

Published:2017-08-27 Issue:12 Volume:83 Page:2661-2670
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Moñux Guillermo¹,Zamorano‐León Jose J.²,Marqués Pablo¹,Sopeña Bernardo²,García‐García J. M.³,Laich de Koller G.⁴,Calvo‐Rico Bibiana³,García‐Fernandez Miguel A.²⁵,Serrano J.¹,López‐Farré Antonio²⁵^ORCID

Affiliation:

1. Vascular Surgery DepartmentHospital Clínico San Carlos Madrid Spain

2. Technological Innovation and Clinical Practice University Class (AINTEC), School of MedicineUniversidad Complutense de Madrid Madrid Spain

3. Physical Activity and Sport Sciences DepartmentUniversidad Castilla‐La Mancha Toledo Spain

4. Universidad Alfonso X el Sabio Madrid Spain

5. Medicine Department, School of MedicineUniversidad Complutense de Madrid Madrid Spain

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.13383

Reference53 articles.

1. Understanding Abdominal Aortic Aneurysm

2. Abdominal Aortic Aneurysm

3. Differential regulation of matrix metalloproteinase activities in abdominal aortic aneurysms

4. Enhanced Expression of Matrix Metalloproteinase-9 in Abdominal Aortic Aneurysms

5. Increased plasma levels of metalloproteinase-9 are associated with abdominal aortic aneurysms

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond Anticoagulation: A Comprehensive Review of Non-Vitamin K Oral Anticoagulants (NOACs) in Inflammation and Protease-Activated Receptor Signaling;International Journal of Molecular Sciences;2024-08-10

2. Vascular protection with rivaroxaban in the comprehensive management of atrial fibrillation;Expert Review of Cardiovascular Therapy;2023-11-02

3. Effects of rivaroxaban on myocardial mitophagy in the rat heart;Turkish Journal of Thoracic and Cardiovascular Surgery;2023-07-01

4. Rivaroxaban in patients with abdominal aortic aneurysm and high-sensitivity C-reactive protein elevation (BANBOO): study protocol for a randomized, controlled trial;Trials;2023-06-19

5. Antioxidant Properties of Oral Antithrombotic Therapies in Atherosclerotic Disease and Atrial Fibrillation;Antioxidants;2023-05-30